Cambridge Investment Research Advisors’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,196
| Closed | -$228K | – | 3775 |
|
|
2025
Q1 | $228K | Sell |
5,196
-246
| -5% | -$10.8K | ﹤0.01% | 3098 |
|
|
2024
Q4 | $234K | Sell |
5,442
-428
| -7% | -$18.4K | ﹤0.01% | 3061 |
|
|
2024
Q3 | $260K | Sell |
5,870
-169
| -3% | -$7.49K | ﹤0.01% | 2938 |
|
|
2024
Q2 | $240K | Sell |
6,039
-365
| -6% | -$14.5K | ﹤0.01% | 2884 |
|
|
2024
Q1 | $276K | Sell |
6,404
-221
| -3% | -$9.53K | ﹤0.01% | 2769 |
|
|
2023
Q4 | $276K | Buy |
+6,625
| New | +$276K | ﹤0.01% | 2655 |
|
|
2023
Q2 | – | Sell |
-5,208
| Closed | -$214K | – | 3307 |
|
|
2023
Q1 | $214K | Buy |
5,208
+4
| +0.1% | +$164 | ﹤0.01% | 2767 |
|
|
2022
Q4 | $213K | Sell |
5,204
-170
| -3% | -$6.96K | ﹤0.01% | 2708 |
|
|
2022
Q3 | $216K | Sell |
5,374
-49
| -0.9% | -$1.97K | ﹤0.01% | 2637 |
|
|
2022
Q2 | $228K | Buy |
5,423
+5
| +0.1% | +$210 | ﹤0.01% | 2612 |
|
|
2022
Q1 | $245K | Sell |
5,418
-639
| -11% | -$28.9K | ﹤0.01% | 2716 |
|
|
2021
Q4 | $280K | Sell |
6,057
-135
| -2% | -$6.24K | ﹤0.01% | 2583 |
|
|
2021
Q3 | $294K | Sell |
6,192
-243
| -4% | -$11.5K | ﹤0.01% | 2484 |
|
|
2021
Q2 | $333K | Sell |
6,435
-165
| -3% | -$8.54K | ﹤0.01% | 2390 |
|
|
2021
Q1 | $332K | Buy |
6,600
+1,002
| +18% | +$50.4K | ﹤0.01% | 2212 |
|
|
2020
Q4 | $291K | Buy |
5,598
+779
| +16% | +$40.5K | ﹤0.01% | 2169 |
|
|
2020
Q3 | $210K | Sell |
4,819
-146
| -3% | -$6.36K | ﹤0.01% | 2202 |
|
|
2020
Q2 | $213K | Buy |
+4,965
| New | +$213K | ﹤0.01% | 2132 |
|
|
2019
Q2 | – | Sell |
-5,575
| Closed | -$232K | – | 2366 |
|
|
2019
Q1 | $232K | Sell |
5,575
-37
| -0.7% | -$1.54K | ﹤0.01% | 1972 |
|
|
2018
Q4 | $206K | Sell |
5,612
-38,774
| -87% | -$1.42M | ﹤0.01% | 1902 |
|
|
2018
Q3 | $2.16M | Buy |
44,386
+37,957
| +590% | +$1.84M | 0.02% | 665 |
|
|
2018
Q2 | $277K | Buy |
6,429
+800
| +14% | +$34.5K | ﹤0.01% | 1792 |
|
|
2018
Q1 | $236K | Buy |
+5,629
| New | +$236K | ﹤0.01% | 1853 |
|
|
2017
Q2 | – | Sell |
-4,973
| Closed | -$208K | – | 1988 |
|
|
2017
Q1 | $208K | Sell |
4,973
-350
| -7% | -$14.6K | ﹤0.01% | 1592 |
|
|
2016
Q4 | $208K | Sell |
5,323
-459
| -8% | -$17.9K | ﹤0.01% | 1482 |
|
|
2016
Q3 | $256K | Sell |
5,782
-17
| -0.3% | -$753 | ﹤0.01% | 1395 |
|
|
2016
Q2 | $242K | Sell |
5,799
-1,469
| -20% | -$61.3K | 0.01% | 1295 |
|
|
2016
Q1 | $292K | Sell |
7,268
-610
| -8% | -$24.5K | 0.01% | 1190 |
|
|
2015
Q4 | $403K | Sell |
7,878
-923
| -10% | -$47.2K | 0.01% | 972 |
|
|
2015
Q3 | $413K | Sell |
8,801
-12,885
| -59% | -$605K | 0.01% | 862 |
|
|
2015
Q2 | $1.35M | Buy |
21,686
+434
| +2% | +$27.1K | 0.04% | 414 |
|
|
2015
Q1 | $1.31M | Buy |
21,252
+6,666
| +46% | +$412K | 0.04% | 418 |
|
|
2014
Q4 | $787K | Buy |
14,586
+5,088
| +54% | +$275K | 0.02% | 573 |
|
|
2014
Q3 | $503K | Buy |
9,498
+474
| +5% | +$25.1K | 0.01% | 825 |
|
|
2014
Q2 | $468K | Sell |
9,024
-562
| -6% | -$29.1K | 0.02% | 783 |
|
|
2014
Q1 | $449K | Buy |
9,586
+3,162
| +49% | +$148K | 0.02% | 762 |
|
|
2013
Q4 | $283K | Buy |
+6,424
| New | +$283K | 0.01% | 915 |
|